Retail sale of pharmaceutical products
VIVIBENE AS
Revenue 2025
NOK 3.8m
Operating profit
NOK −214,000
Equity
NOK 668,000
Incorporated
2019
Share capital
NOK 650,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 3.8m | |
| Total operating costs | 4.0m | |
| Operating profit (EBIT) | −214k | |
| Net financial items | −20k | |
| Profit for the year | −234k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 876k | |
| of which current assets | 793k | |
| Equity | 668k | |
| Total liabilities | 208k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.